Sort
85,873 grants matching “alzheimers”
Role of Lifespan Intervention on the Regulation and Progression of Alzheimer's Disease
$990,311Stacey J Rizzo · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AG
Brain Health and Ethnic Disparities in ADRD Risk: The Case of Arab Americans
$990,293Toni Claudette Antonucci · University Of Michigan At Ann Arbor · R01 · FY2025 · AG
Adult Changes in Thought (ACT) Research Program Core D: Neuropathology Core
$990,188Christopher D Keene · Kaiser Foundation Research Institute · U19 · FY2023 · AG
HRS Yrs 29-34: Covid Antibody Revision
$990,154David R. Weir · University Of Michigan At Ann Arbor · U01 · FY2022 · AG
ALZHEIMER'S DISEASE AND ANIMAL MODELS
$990,000Johns Hopkins University · P50 · FY2004 · AG
Developing novel strategies for personalized treatment and prevention of ALS: Leveraging the global exposome, genome, epigenome, metabolome, and inflammasome with data science in a case/control cohort
$989,984Eva L Feldman · University Of Michigan At Ann Arbor · R01 · FY2021 · NS
Searching for the Goldilocks Zone of Innate Immunity in Alzheimer's Disease
$989,879Todd E. Golde · Emory University · R01 · FY2025 · AG
Epidemiology of Aging and Dementia-Autopsy Research
$989,777Lon Ray White · Kuakini Medical Center · R01 · FY2006 · AG
STANFORD ALZHEIMER'S DISEASE CORE CENTER
$989,724Stanford University · P30 · FY2003 · AG
NEUROSCIENCE CORE CENTER
$989,708Francis W Flynn · University Of Wyoming · P30 · FY2015 · GM
NEUROSCIENCE CORE CENTER
$989,376Francis W Flynn · University Of Wyoming · P30 · FY2014 · GM
Mindfulness-based Cognitive Coping Mobile App Intervention for caregivers of individuals with Alzheimer's Disease
$989,297Bruno Kajiyama · Photozig, Inc. · R44 · FY2022 · AG
High-Throughput System for Protease Activity Profiling
$989,116Igor A. Kozlov · Prognosys Biosciences, Inc. · R44 · FY2012 · GM
Integrating the exposome and methylome to inform brain molecular changes in ADRD across established diverse cohorts.
$988,968Nilufer Ertekin-Taner · Mayo Clinic Jacksonville · U01 · FY2022 · AG
Optimization of small molecule SERCA2b activators to inhibit neuron loss in Alzheimer's disease
$988,940Russell Dahl · Neurodon Llc · R42 · FY2020 · AG
Environmental Exposome as a Driver in Alzheimerâs Disease
$988,863Dwight C. German · Ut Southwestern Medical Center · R01 · FY2025 · AG
From Structure to Therapy: The TRiC Chaperonin Network in Huntington's Disease
$988,674Leslie Michels Thompson · University Of California-Irvine · P01 · FY2020 · NS
Implementation Core
$988,674Corita R Grudzen · New York University School Of Medicine · U19 · FY2023 · AG
Retinal image analysis software for neurodegenerative disease research
$988,633Daniel Russakoff · Voxeleron, Llc · R44 · FY2021 · TR
Neuroimaging Core
$988,551Susan Y Bookheimer · Boston University Medical Campus · U19 · FY2021 · AG
A Phase 1b Multiple Ascending Dose Study of the Safety and Tolerability of BMS-984923 in Alzheimer's Disease
$988,498Adam Peter Mecca · Yale University · R01 · FY2023 · AG
Pesticides, Olfaction, and Neurodegeneration Among US Farmers
$988,470Honglei Chen · Michigan State University · R01 · FY2020 · ES
NEUROSCIENCE CORE CENTER
$988,402Francis W Flynn · University Of Wyoming · P30 · FY2012 · GM
Imaging Core (Core C)
$988,318Keith A. Johnson · Massachusetts General Hospital · P01 · FY2022 · AG
Study of protein folding and misfolding by NMR spectroscopy
$988,068Adriaan Bax · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK